Logo image of CLARI.PA

CLARIANE SE (CLARI.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:CLARI - FR0010386334 - Common Stock

3.554 EUR
-0.03 (-0.89%)
Last: 12/16/2025, 12:24:38 PM
Fundamental Rating

3

CLARI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 31 industry peers in the Health Care Providers & Services industry. CLARI has a bad profitability rating. Also its financial health evaluation is rather negative. CLARI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CLARI has reported negative net income.
In the past year CLARI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLARI reported negative net income in multiple years.
CLARI had a positive operating cash flow in each of the past 5 years.
CLARI.PA Yearly Net Income VS EBIT VS OCF VS FCFCLARI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

With a Return On Assets value of -0.43%, CLARI is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
CLARI has a worse Return On Equity (-1.71%) than 77.42% of its industry peers.
CLARI has a Return On Invested Capital of 1.63%. This is amonst the worse of the industry: CLARI underperforms 83.87% of its industry peers.
CLARI had an Average Return On Invested Capital over the past 3 years of 1.96%. This is below the industry average of 6.10%.
Industry RankSector Rank
ROA -0.43%
ROE -1.71%
ROIC 1.63%
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
CLARI.PA Yearly ROA, ROE, ROICCLARI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

CLARI has a Operating Margin (4.80%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CLARI has declined.
With an excellent Gross Margin value of 91.90%, CLARI belongs to the best of the industry, outperforming 93.55% of the companies in the same industry.
In the last couple of years the Gross Margin of CLARI has remained more or less at the same level.
Industry RankSector Rank
OM 4.8%
PM (TTM) N/A
GM 91.9%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
CLARI.PA Yearly Profit, Operating, Gross MarginsCLARI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1

2. Health

2.1 Basic Checks

CLARI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CLARI has been increased compared to 1 year ago.
The number of shares outstanding for CLARI has been increased compared to 5 years ago.
Compared to 1 year ago, CLARI has an improved debt to assets ratio.
CLARI.PA Yearly Shares OutstandingCLARI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CLARI.PA Yearly Total Debt VS Total AssetsCLARI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

CLARI has an Altman-Z score of 0.62. This is a bad value and indicates that CLARI is not financially healthy and even has some risk of bankruptcy.
CLARI has a Altman-Z score of 0.62. This is amonst the worse of the industry: CLARI underperforms 80.65% of its industry peers.
CLARI has a debt to FCF ratio of 13.25. This is a negative value and a sign of low solvency as CLARI would need 13.25 years to pay back of all of its debts.
CLARI has a worse Debt to FCF ratio (13.25) than 61.29% of its industry peers.
A Debt/Equity ratio of 1.90 is on the high side and indicates that CLARI has dependencies on debt financing.
The Debt to Equity ratio of CLARI (1.90) is worse than 70.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.9
Debt/FCF 13.25
Altman-Z 0.62
ROIC/WACC0.43
WACC3.77%
CLARI.PA Yearly LT Debt VS Equity VS FCFCLARI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 0.67 indicates that CLARI may have some problems paying its short term obligations.
CLARI's Current ratio of 0.67 is on the low side compared to the rest of the industry. CLARI is outperformed by 74.19% of its industry peers.
CLARI has a Quick Ratio of 0.67. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
CLARI's Quick ratio of 0.65 is in line compared to the rest of the industry. CLARI outperforms 41.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.65
CLARI.PA Yearly Current Assets VS Current LiabilitesCLARI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 84.49% over the past year.
Looking at the last year, CLARI shows a small growth in Revenue. The Revenue has grown by 2.70% in the last year.
CLARI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.89% yearly.
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%

3.2 Future

Based on estimates for the next years, CLARI will show a very strong growth in Earnings Per Share. The EPS will grow by 35.01% on average per year.
The Revenue is expected to grow by 3.26% on average over the next years.
EPS Next Y130.5%
EPS Next 2Y74.69%
EPS Next 3Y53.72%
EPS Next 5Y35.01%
Revenue Next Year0.99%
Revenue Next 2Y2.46%
Revenue Next 3Y3.12%
Revenue Next 5Y3.26%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLARI.PA Yearly Revenue VS EstimatesCLARI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B
CLARI.PA Yearly EPS VS EstimatesCLARI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLARI. In the last year negative earnings were reported.
CLARI is valuated correctly with a Price/Forward Earnings ratio of 13.80.
CLARI's Price/Forward Earnings is on the same level as the industry average.
CLARI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 13.8
CLARI.PA Price Earnings VS Forward Price EarningsCLARI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

CLARI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CLARI is cheaper than 70.97% of the companies in the same industry.
CLARI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CLARI is cheaper than 96.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.05
EV/EBITDA 8.35
CLARI.PA Per share dataCLARI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLARI's earnings are expected to grow with 53.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.69%
EPS Next 3Y53.72%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.64%, CLARI is a good candidate for dividend investing.
CLARI's Dividend Yield is rather good when compared to the industry average which is at 1.72. CLARI pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, CLARI pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.64%

5.2 History

The dividend of CLARI decreases each year by -7.26%.
Dividend Growth(5Y)-7.26%
Div Incr Years0
Div Non Decr Years0
CLARI.PA Yearly Dividends per shareCLARI.PA Yearly Dividends per shareYearly Dividends per share 2023 0.05 0.1 0.15 0.2

5.3 Sustainability

The earnings of CLARI are negative and hence is the payout ratio. CLARI will probably not be able to sustain this dividend level.
DP-110.43%
EPS Next 2Y74.69%
EPS Next 3Y53.72%
CLARI.PA Yearly Income VS Free CF VS DividendCLARI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

CLARIANE SE

EPA:CLARI (12/16/2025, 12:24:38 PM)

3.554

-0.03 (-0.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-27 2025-10-27
Earnings (Next)02-26 2026-02-26/amc
Inst Owners45.11%
Inst Owner ChangeN/A
Ins Owners5.61%
Ins Owner ChangeN/A
Market Cap1.27B
Revenue(TTM)5.31B
Net Income(TTM)-61.38M
Analysts77.14
Price Target4.52 (27.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.64%
Yearly Dividend0.19
Dividend Growth(5Y)-7.26%
DP-110.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.66%
PT rev (3m)-5.51%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-17.14%
EPS NY rev (3m)-52.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-1.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.8
P/S 0.24
P/FCF 2.05
P/OCF 1.44
P/B 0.35
P/tB N/A
EV/EBITDA 8.35
EPS(TTM)-0.17
EYN/A
EPS(NY)0.26
Fwd EY7.25%
FCF(TTM)1.73
FCFY48.74%
OCF(TTM)2.47
OCFY69.62%
SpS14.88
BVpS10.05
TBVpS-5.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.43%
ROE -1.71%
ROCE 2.21%
ROIC 1.63%
ROICexc 1.74%
ROICexgc 3.53%
OM 4.8%
PM (TTM) N/A
GM 91.9%
FCFM 11.64%
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexgc growth 3Y-9.02%
ROICexgc growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.9
Debt/FCF 13.25
Debt/EBITDA 6.54
Cap/Depr 33.63%
Cap/Sales 4.99%
Interest Coverage 0.83
Cash Conversion 84.71%
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.65
Altman-Z 0.62
F-Score6
WACC3.77%
ROIC/WACC0.43
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
EPS Next Y130.5%
EPS Next 2Y74.69%
EPS Next 3Y53.72%
EPS Next 5Y35.01%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
Revenue Next Year0.99%
Revenue Next 2Y2.46%
Revenue Next 3Y3.12%
Revenue Next 5Y3.26%
EBIT growth 1Y-22.25%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year283.2%
EBIT Next 3Y64.52%
EBIT Next 5Y37.84%
FCF growth 1Y267.6%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.15%
OCF growth 3Y2.33%
OCF growth 5Y3.29%

CLARIANE SE / CLARI.PA FAQ

What is the ChartMill fundamental rating of CLARIANE SE (CLARI.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CLARI.PA.


What is the valuation status for CLARI stock?

ChartMill assigns a valuation rating of 5 / 10 to CLARIANE SE (CLARI.PA). This can be considered as Fairly Valued.


What is the profitability of CLARI stock?

CLARIANE SE (CLARI.PA) has a profitability rating of 3 / 10.


How sustainable is the dividend of CLARIANE SE (CLARI.PA) stock?

The dividend rating of CLARIANE SE (CLARI.PA) is 5 / 10 and the dividend payout ratio is -110.43%.